1200PSerum biomarkers during the first cycle of anti-PD-1 antibody therapies in non-small cell lung cancer. (23rd October 2018) - Ota, T; Takeda, T; Fukui, T; Nakahara, Y; Kudo, K; Okabe, T; Hayashi, H; Otani, S; Hiyoshi, Y; Yonesaka, K; Sugiura, T; Suzumura, T; et al.